Trends in Antimicrobial Susceptibility of Escherichia coli Isolates in a Taiwanese Child Cohort with Urinary Tract Infections between 2004 and 2018
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Data Source
2.2. Outcome Measurements
2.3. Statistical Analysis
3. Results
3.1. Incidence of E. coli in Community-Associated UTIs
3.2. Trends in Antimicrobial-Drugs-Resistant E. coli Isolates in CA-UTIs
3.3. Outcomes and Factors Associated with E. coli Resistance to Third Generation Cephalosporin
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Shaikh, N.; Ewing, A.L.; Bhatnagar, S.; Hoberman, A. Risk of renal scarring in children with a first urinary tract infection: A systematic review. Pediatrics 2010, 126, 1084–1091. [Google Scholar] [CrossRef] [Green Version]
- Korbel, L.; Howell, M.; Spencer, J.D. The clinical diagnosis and management of urinary tract infections in children and adolescents. Paediatr. Int. Child Health 2017, 37, 273–279. [Google Scholar] [CrossRef]
- Leung, A.K.C.; Wong, A.H.C.; Leung, A.A.M.; Hon, K.L. Urinary Tract Infection in Children. Recent. Pat. Inflamm. Allergy Drug Discov. 2019, 13, 2–18. [Google Scholar] [CrossRef]
- Wang, J.T.; Chang, S.C.; Chang, F.Y.; Fung, C.P.; Chuang, Y.C.; Chen, Y.S.; Shiau, Y.R.; Tan, M.C.; Wang, H.Y.; Lai, J.F.; et al. Antimicrobial Non-Susceptibility of Escherichia coli from Outpatients and Patients Visiting Emergency Rooms in Taiwan. PLoS ONE 2015, 10, e0144103. [Google Scholar] [CrossRef] [Green Version]
- Lin, W.P.; Huang, Y.S.; Wang, J.T.; Chen, Y.C.; Chang, S.C. Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan. BMC Infect. Dis. 2019, 19, 245. [Google Scholar] [CrossRef] [Green Version]
- Parajuli, N.P.; Maharjan, P.; Parajuli, H.; Joshi, G.; Paudel, D.; Sayami, S.; Khanal, P.R. High rates of multidrug resistance among uropathogenic Escherichia coli in children and analyses of ESBL producers from Nepal. Antimicrob. Resist. Infect. Control 2017, 6, 9. [Google Scholar] [CrossRef] [Green Version]
- Mazzariol, A.; Bazaj, A.; Cornaglia, G. Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: A review. J. Chemother. 2017, 29, 2–9. [Google Scholar] [CrossRef] [Green Version]
- Paterson, D.L.; Bonomo, R.A. Extended-spectrum beta-lactamases: A clinical update. Clin. Microbiol. Rev. 2005, 18, 657–686. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Flokas, M.E.; Detsis, M.; Alevizakos, M.; Mylonakis, E. Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: A systematic review and meta-analysis. J. Infect. 2016, 73, 547–557. [Google Scholar] [CrossRef] [PubMed]
- Sood, A.; Penna, F.J.; Eleswarapu, S.; Pucheril, D.; Weaver, J.; Abd-El-Barr, A.E.; Wagner, J.C.; Lakshmanan, Y.; Menon, M.; Trinh, Q.D.; et al. Incidence, admission rates, and economic burden of pediatric emergency department visits for urinary tract infection: Data from the nationwide emergency department sample, 2006 to 2011. J. Pediatr. Urol. 2015, 11, 246.e1–246.e8. [Google Scholar] [CrossRef] [PubMed]
- Fan, N.C.; Chen, H.H.; Chen, C.L.; Ou, L.S.; Lin, T.Y.; Tsai, M.H.; Chiu, C.H. Rise of community-onset urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli in children. J. Microbiol. Immunol. Infect. 2014, 47, 399–405. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Vihta, K.D.; Stoesser, N.; Llewelyn, M.J.; Quan, T.P.; Davies, T.; Fawcett, N.J.; Dunn, L.; Jeffery, K.; Butler, C.C.; Hayward, G.; et al. Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998-2016: A study of electronic health records. Lancet Infect. Dis. 2018, 18, 1138–1149. [Google Scholar] [CrossRef] [Green Version]
- McDanel, J.; Schweizer, M.; Crabb, V.; Nelson, R.; Samore, M.; Khader, K.; Blevins, A.E.; Diekema, D.; Chiang, H.Y.; Nair, R.; et al. Incidence of Extended-Spectrum beta-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella Infections in the United States: A Systematic Literature Review. Infect. Control Hosp. Epidemiol. 2017, 38, 1209–1215. [Google Scholar] [CrossRef] [PubMed]
- Kizilca, O.; Siraneci, R.; Yilmaz, A.; Hatipoglu, N.; Ozturk, E.; Kiyak, A.; Ozkok, D. Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children. Pediatr. Int. 2012, 54, 858–862. [Google Scholar] [CrossRef] [PubMed]
- Kim, Y.H.; Yang, E.M.; Kim, C.J.; Hernandez Marco, R.; Guillen Olmos, E.; Breton-Martinez, J.R.; Giner Perez, L.; Casado Sanchez, B.; Fujkova, J.; Salamanca Campos, M.; et al. Urinary tract infection caused by community-acquired extended-spectrum beta-lactamase-producing bacteria in infants. J. Pediatr. 2017, 93, 260–266. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhu, F.H.; Rodado, M.P.; Asmar, B.I.; Salimnia, H.; Thomas, R.; Abdel-Haq, N. Risk factors for community acquired urinary tract infections caused by extended spectrum beta-lactamase (ESBL) producing Escherichia coli in children: A case control study. Infect. Dis. 2019, 51, 802–809. [Google Scholar] [CrossRef]
- Roldan-Masedo, E.; Sainz, T.; Gutierrez-Arroyo, A.; Gomez-Gil, R.M.; Ballesteros, E.; Escosa, L.; Baquero-Artigao, F.; Mendez-Echevarria, A. Risk factors for gentamicin-resistant E. coli in children with community-acquired urinary tract infection. Eur. J. Clin. Microbiol. Infect. Dis. 2019, 38, 2097–2102. [Google Scholar] [CrossRef]
- Chen, P.C.; Chang, L.Y.; Lu, C.Y.; Shao, P.L.; Tsai, I.J.; Tsau, Y.K.; Lee, P.I.; Chen, J.M.; Hsueh, P.R.; Huang, L.M. Drug susceptibility and treatment response of common urinary tract infection pathogens in children. J. Microbiol. Immunol. Infect. 2014, 47, 478–483. [Google Scholar] [CrossRef]
- Cheng, M.F.; Chen, W.L.; Hung, W.Y.; Huang, I.F.; Chiou, Y.H.; Chen, Y.S.; Lee, S.S.; Hung, C.H.; Wang, J.L. Emergence of extended spectrum-beta-lactamase-producing Escherichia coli O25b-ST131: A major community-acquired uropathogen in infants. Pediatr. Infect. Dis. J. 2015, 34, 469–475. [Google Scholar] [CrossRef]
- Perez Heras, I.; Sanchez-Gomez, J.C.; Beneyto-Martin, P.; Ruano-de-Pablo, L.; Losada-Pinedo, B. Community-onset extended-spectrum beta-lactamase producing Escherichia coli in urinary tract infections in children from 2015 to 2016: Prevalence, risk factors, and resistances. Medicine 2017, 96, e8571. [Google Scholar] [CrossRef]
- Shao, S.C.; Chan, Y.Y.; Kao Yang, Y.H.; Lin, S.J.; Hung, M.J.; Chien, R.N.; Lai, C.C.; Lai, E.C. The Chang Gung Research Database-A multi-institutional electronic medical records database for real-world epidemiological studies in Taiwan. Pharmacoepidemiol. Drug Saf. 2019, 28, 593–600. [Google Scholar] [CrossRef] [PubMed]
- Stein, R.; Dogan, H.S.; Hoebeke, P.; Kocvara, R.; Nijman, R.J.; Radmayr, C.; Tekgul, S.; European Association of Urology; European Society for Pediatric Urology. Urinary tract infections in children: EAU/ESPU guidelines. Eur. Urol. 2015, 67, 546–558. [Google Scholar] [CrossRef] [PubMed]
- Subcommittee on Urinary Tract Infection; Steering Committee on Quality Improvement and Management; Roberts, K.B. Urinary tract infection: Clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011, 128, 595–610. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Horan, T.C.; Andrus, M.; Dudeck, M.A. CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control 2008, 36, 309–332. [Google Scholar] [CrossRef] [PubMed]
- Simon, T.D.; Cawthon, M.L.; Popalisky, J.; Mangione-Smith, R. Development and Validation of the Pediatric Medical Complexity Algorithm (PMCA) Version 2.0. Hosp. Pediatr. 2017, 7, 373–377. [Google Scholar] [CrossRef] [Green Version]
- Simon, T.D.; Haaland, W.; Hawley, K.; Lambka, K.; Mangione-Smith, R. Development and Validation of the Pediatric Medical Complexity Algorithm (PMCA) Version 3.0. Acad. Pediatr. 2018, 18, 577–580. [Google Scholar] [CrossRef]
- Morrissey, I.; Hackel, M.; Badal, R.; Bouchillon, S.; Hawser, S.; Biedenbach, D. A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011. Pharmaceuticals 2013, 6, 1335–1346. [Google Scholar] [CrossRef] [Green Version]
- Fasugba, O.; Gardner, A.; Mitchell, B.G.; Mnatzaganian, G. Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: A systematic review and meta-analysis of observational studies. BMC Infect. Dis. 2015, 15, 545. [Google Scholar] [CrossRef] [Green Version]
- Hernandez Marco, R.; Guillen Olmos, E.; Breton-Martinez, J.R.; Giner Perez, L.; Casado Sanchez, B.; Fujkova, J.; Salamanca Campos, M.; Nogueira Coito, J.M. Community-acquired febrile urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in hospitalised infants. Enferm. Infecc. Microbiol. Clin. 2017, 35, 287–292. [Google Scholar] [CrossRef]
- Cohen, E.; Kuo, D.Z.; Agrawal, R.; Berry, J.G.; Bhagat, S.K.; Simon, T.D.; Srivastava, R. Children with medical complexity: An emerging population for clinical and research initiatives. Pediatrics 2011, 127, 529–538. [Google Scholar] [CrossRef] [Green Version]
- Edwards, J.D.; Houtrow, A.J.; Vasilevskis, E.E.; Rehm, R.S.; Markovitz, B.P.; Graham, R.J.; Dudley, R.A. Chronic conditions among children admitted to U.S. pediatric intensive care units: Their prevalence and impact on risk for mortality and prolonged length of stay*. Crit. Care Med. 2012, 40, 2196–2203. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Topaloglu, R.; Er, I.; Dogan, B.G.; Bilginer, Y.; Ozaltin, F.; Besbas, N.; Ozen, S.; Bakkaloglu, A.; Gur, D. Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children. Pediatr. Nephrol. 2010, 25, 919–925. [Google Scholar] [CrossRef] [PubMed]
- Zegers, S.H.; Dieleman, J.; van der Bruggen, T.; Kimpen, J.; de Jong-de Vos van Steenwijk, C. The influence of antibiotic prophylaxis on bacterial resistance in urinary tract infections in children with spina bifida. BMC Infect. Dis. 2017, 17, 63. [Google Scholar] [CrossRef] [Green Version]
- Shaikh, N.; Craig, J.C.; Rovers, M.M.; Da Dalt, L.; Gardikis, S.; Hoberman, A.; Montini, G.; Rodrigo, C.; Taskinen, S.; Tuerlinckx, D.; et al. Identification of children and adolescents at risk for renal scarring after a first urinary tract infection: A meta-analysis with individual patient data. JAMA Pediatr. 2014, 168, 893–900. [Google Scholar] [CrossRef] [PubMed]
- Wang, M.E.; Lee, V.; Greenhow, T.L.; Beck, J.; Bendel-Stenzel, M.; Hames, N.; McDaniel, C.E.; King, E.E.; Sherry, W.; Parmar, D.; et al. Clinical Response to Discordant Therapy in Third-Generation Cephalosporin-Resistant UTIs. Pediatrics 2020, 145, e20191608. [Google Scholar] [CrossRef] [PubMed]
- Shaikh, N.; Hoberman, A.; Hum, S.W.; Alberty, A.; Muniz, G.; Kurs-Lasky, M.; Landsittel, D.; Shope, T. Development and Validation of a Calculator for Estimating the Probability of Urinary Tract Infection in Young Febrile Children. JAMA Pediatr. 2018, 172, 550–556. [Google Scholar] [CrossRef] [Green Version]
- Zingg, W.; Hopkins, S.; Gayet-Ageron, A.; Holmes, A.; Sharland, M.; Suetens, C.; Almeida, M.; Asembergiene, J.; Borg, M.A.; Budimir, A. Health-care-associated infections in neonates, children, and adolescents: An analysis of paediatric data from the European Centre for Disease Prevention and Control point-prevalence survey. Lancet Infect. Dis. 2017, 17, 381–389. [Google Scholar] [CrossRef]
- Downs, S.M. Technical report: Urinary tract infections in febrile infants and young children. The Urinary Tract Subcommittee of the American Academy of Pediatrics Committee on Quality Improvement. Pediatrics 1999, 103, e54. [Google Scholar] [CrossRef] [Green Version]
Heading | Overall * | 3GCs-Resistant (n = 822) | 3GCs-Susceptible (n = 6556) | p-Value # | ||
---|---|---|---|---|---|---|
N | n | (%) | n | (%) | ||
In-hospital death | 27 | 6 | (0.73) | 21 | (0.32) | 0.1133 |
Length of stay (day), | <0.0001 | |||||
Mean (SD) | 7378 | 8.09 | (4.59) | 6.78 | (3.53) | |
Median (IQR) | 7.00 | (5.00–10.00) | 6.00 | (5.00–8.00) | ||
Discharge diagnosis with bacteremia | 311 | 45 | (5.47) | 266 | (4.06) | 0.0566 |
E. coli | 106 | 13 | (1.58) | 93 | (1.42) | 0.7113 |
Heading | Overall * | 3GCs-Resistant (n = 822) | 3GCs-Susceptible (n = 6556) | p-Value # | ||
---|---|---|---|---|---|---|
n | n | (%) | n | (%) | ||
Age at admission | 0.4516 | |||||
≤28 days | 379 | 39 | (4.74) | 340 | (5.19) | |
29 days to < 1 year | 5534 | 634 | (77.13) | 4900 | (74.74) | |
1 to 2 years | 808 | 86 | (10.46) | 722 | (11.01) | |
3 to 17 years | 657 | 63 | (7.66) | 594 | (9.06) | |
Sex | 0.0415 | |||||
Boys | 4189 | 494 | (60.10) | 3695 | (56.36) | |
Girls | 3189 | 328 | (39.90) | 2861 | (43.64) | |
Recent medical visits ≤ 3 months prior, visit | ||||||
Outpatient | 0.4501 | |||||
None | 6410 | 721 | (87.71) | 5689 | (86.78) | |
1–3 | 722 | 71 | (8.64) | 651 | (9.93) | |
≥4 | 246 | 30 | (3.65) | 216 | (3.29) | |
Emergency department | 0.2825 | |||||
None | 6911 | 764 | (92.94) | 6147 | (93.76) | |
1 | 365 | 49 | (5.96) | 316 | (4.82) | |
≥2 | 102 | 9 | (1.09) | 93 | (1.42) | |
Hospitalization | 0.0834 | |||||
None | 7070 | 784 | (95.38) | 6286 | (95.88) | |
1 | 279 | 31 | (3.77) | 248 | (3.78) | |
≥2 | 29 | 7 | (0.85) | 22 | (0.34) | |
PMCA, CD | <0.0001 | |||||
Without CD | 6640 | 724 | (88.08) | 5916 | (90.24) | |
Non-complex CD | 442 | 40 | (4.87) | 402 | (6.13) | |
Complex CD | 296 | 58 | (7.06) | 238 | (3.63) | |
Recent antibiotic treatment ≤ 3 months prior | ||||||
Sum of regimen | <0.0001 | |||||
None | 6427 | 674 | (82.00) | 5753 | (87.75) | |
1 | 515 | 79 | (9.61) | 436 | (6.65) | |
≥2 | 436 | 69 | (8.39) | 367 | (5.60) | |
Amoxicillin/clavulanic acid | 286 | 49 | (5.96) | 237 | (3.62) | 0.0010 |
Amikacin | 11 | 6 | (0.73) | 5 | (0.08) | <0.0001 |
Ciprofloxacin | 9 | 5 | (0.61) | 4 | (0.06) | <0.0001 |
Ceftriaxone | 38 | 9 | (1.09) | 29 | (0.44) | 0.0137 |
Cefazolin | 37 | 10 | (1.22) | 27 | (0.41) | 0.0021 |
Ertapenem | 412 | 63 | (7.66) | 349 | (5.32) | 0.0059 |
Gentamicin | 550 | 75 | (9.12) | 475 | (7.25) | 0.0532 |
Levofloxacin | 1 | 0 | (0.00) | 1 | (0.02) | -- |
Sulfamethoxazole–Trimethoprim | 133 | 36 | (4.38) | 97 | (1.48) | <0.0001 |
Piperacillin/Tazobactam | 2 | 1 | (0.12) | 1 | (0.02) | -- |
Heading | aOR | 95%CI | p-Value | |
---|---|---|---|---|
Age at index hospitalization | ||||
≤28 days | 1 | |||
29 days to < 1 year | 1.08 | (0.77 | 1.52) | 0.6589 |
1 to 2 years | 0.98 | (0.65 | 1.47) | 0.9059 |
3 to 17 years | 0.80 | (0.51 | 1.24) | 0.3075 |
Boy (vs. girl) | 1.13 | (0.96 | 1.32) | 0.1337 |
Healthcare service use ≤3 months prior, visit | ||||
Outpatient setting | ||||
None | 1 | |||
1–3 | 0.80 | (0.60 | 1.08) | 0.1449 |
≥4 | 0.70 | (0.43 | 1.13) | 0.1434 |
Emergency department | ||||
None | 1 | |||
1 | 1.34 | (0.95 | 1.88) | 0.0910 |
≥2 | 0.77 | (0.37 | 1.59) | 0.4785 |
Hospitalization | ||||
None | 1 | |||
1 | 0.98 | (0.63 | 1.53) | 0.9414 |
≥2 | 2.15 | (0.83 | 5.58) | 0.1176 |
PMCA, CD | ||||
Non-Chronic | 1 | |||
Non-complex Chronic | 0.83 | (0.59 | 1.18) | 0.3005 |
Complex Chronic | 2.04 | (1.47 | 2.83) | <0.0001 |
Sum of antibiotic regimen use ≤ 3 months prior | ||||
None | 1 | |||
1 | 1.49 | (1.15 | 1.94) | 0.0031 |
≥2 | 1.53 | (1.16 | 2.02) | 0.0024 |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Chen, H.-E.; Tain, Y.-L.; Kuo, H.-C.; Hsu, C.-N. Trends in Antimicrobial Susceptibility of Escherichia coli Isolates in a Taiwanese Child Cohort with Urinary Tract Infections between 2004 and 2018. Antibiotics 2020, 9, 501. https://doi.org/10.3390/antibiotics9080501
Chen H-E, Tain Y-L, Kuo H-C, Hsu C-N. Trends in Antimicrobial Susceptibility of Escherichia coli Isolates in a Taiwanese Child Cohort with Urinary Tract Infections between 2004 and 2018. Antibiotics. 2020; 9(8):501. https://doi.org/10.3390/antibiotics9080501
Chicago/Turabian StyleChen, Hung-En, You-Lin Tain, Hsiao-Ching Kuo, and Chien-Ning Hsu. 2020. "Trends in Antimicrobial Susceptibility of Escherichia coli Isolates in a Taiwanese Child Cohort with Urinary Tract Infections between 2004 and 2018" Antibiotics 9, no. 8: 501. https://doi.org/10.3390/antibiotics9080501
APA StyleChen, H. -E., Tain, Y. -L., Kuo, H. -C., & Hsu, C. -N. (2020). Trends in Antimicrobial Susceptibility of Escherichia coli Isolates in a Taiwanese Child Cohort with Urinary Tract Infections between 2004 and 2018. Antibiotics, 9(8), 501. https://doi.org/10.3390/antibiotics9080501